AstraZeneca PLC operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares AstraZeneca PLC with three other
pharmaceutical manufacturers in Europe:
sales of £23.92 billion [US$29.32 billion]
of which 59%
(12.84 billion Euro [US$13.65 billion]
of which 54%
was Healthcare), and
Novo Nordisk As
based in Denmark
(107.93 billion Danish Kroner [US$15.43 billion]
of which 79%
was Diabetes Care).
During the year ended December of 2015, sales at
AstraZeneca PLC were £16.20 billion (US$19.86 billion).
increase of 2.2%
versus 2014, when the company's sales were £15.85 billion.
Despite this increase, sales are still
below the level achieved in 2013, when AstraZeneca PLC
reported sales of £16.41 billion.